Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01363882 · ClinicalTrials.gov registry record · NA
Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT01363882 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 25 participants.
The verdict
NCT01363882, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Use of noninvasive ventilation (NIV, also known colloquially as "Bipap") has been associated in some studies with improvement in pulmonary function, quality of life and survival. NIV is typically applied during sleep, and without the benefit of sleep study to determine the optimal settings. The investigators have shown that when NIV is used in this fashion, failure of nocturnal oxygenation and ventilation is prominent. This study is randomizing patients to standard application of NIV vs application guided by use of sleep study data to determine the effect of titrated therapy on pulmonary function, quality of life and survival.
Interventions
- OTHER Sleep study-guided adjustment of NIV
- OTHER Standard initiation of NIV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01363882
The ClinicalTrials.gov registry entry for NCT01363882 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sleep study-guided adjustment of NIV is the first listed.
NCT01363882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01363882 about?
NCT01363882 is a clinical study titled "Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)". Use of noninvasive ventilation (NIV, also known colloquially as "Bipap") has been associated in some studies with improvement in pulmonary function, quality of life and survival. NIV is typically applied during sleep, and without the benefit of sleep study to determine the optimal settings. The inve...
What is the current status of trial NCT01363882?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2008-02. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01363882?
The interventions under investigation include: Sleep study-guided adjustment of NIV (OTHER), Standard initiation of NIV (OTHER).
Who is sponsoring clinical trial NCT01363882?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.